PTD-DBM vial
Hair & Skin

PTD-DBM

PTD-DBM - peptide for Wnt pathway activation. Research application in hair follicle regeneration models.

Unit price -

Sizes and prices

Sizes and prices

Content per vial 5mg Total content 50 mg 10-pack 710 EUR Per vial 71 €
Calculate for this product

Opens the reconstitution calculator with this product's vial size.

Knowledge

What you need to know

Description

PTD-DBM is a synthetic peptide that blocks the CXXC5-Dishevelled interaction and thereby activates the Wnt/beta-catenin signaling pathway. The substance was developed by Korean research teams with primary research focus on hair follicle regeneration in alopecia models.

Per study reports PTD-DBM blocks negative Wnt regulation by CXXC5. Wnt activation in the hair follicle bulge is one of the central pathways for the anagen phase of the hair cycle - activation in research models shows stimulation of follicle neogenesis and accelerated wound healing in skin models.

A landmark publication in Journal of Investigative Dermatology 2017 documented topical PTD-DBM application in mice with dramatic hair regeneration in alopecic areas. The substance is now a young but exciting compound in the recreational community for hair restoration.

Typical application is topical (microneedling setup) - injection or systemic application isn’t established in research literature.

You can order PTD-DBM as lyophilized peptide in 10-pack at 5mg per vial.

This information is for research and educational purposes only. No medical recommendations.

Risks & Safety

PTD-DBM is a young compound applied primarily topically. Systemic exposure is low with topical application, but the overall data is thin.

Observed in the literature and user reports:

  • Local skin reactions: with topical application, particularly in combination with microneedling, redness, irritation or transient sensitivity of the treated skin areas is the most common observation.
  • Wnt pathway activation: the compound activates the Wnt/beta-catenin signaling pathway. This pathway is broadly involved in cell proliferation, and the longer-term effects of repeated local activation are not conclusively characterized in the literature.
  • Application route: injection or systemic application is not established in the research literature, so there is no data basis for non-topical routes.
  • No long-term data: robust human studies exist only to a limited extent. The profile rests on a small number of dermatological studies and anecdotal experience.

This classification does not replace medical advice. Risk and responsibility for any actual use lie entirely with the buyer.

Studies

Dosing recommendation

Members only

Dosing recommendations are visible to logged-in members only. Logging in is free.

Log in / sign up
Lexicon PTD-DBM: full deep-dive Mechanism, reconstitution calculator, realistic dosing and the studies.

Related

Related products